Invention Grant
- Patent Title: Immunopotentiating compounds
- Patent Title (中): 免疫增强化合物
-
Application No.: US12294237Application Date: 2007-03-23
-
Publication No.: US08063063B2Publication Date: 2011-11-22
- Inventor: James Sutton , Nicholas Valiante
- Applicant: James Sutton , Nicholas Valiante
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Helen Lee; Otis Littlefield
- International Application: PCT/US2007/064857 WO 20070323
- International Announcement: WO2007/109812 WO 20070927
- Main IPC: A01N43/42
- IPC: A01N43/42 ; A61K31/44 ; C07D471/02 ; C07D491/02 ; C07D498/02 ; C07D513/02

Abstract:
The invention provides novel compositions comprising Imidazopyridine compounds. Also provided are methods of administering the compositions in an effective amount to enhance the immune response of a subject. Further provided are novel compositions and methods of administering the compositions in combination with (an)other agent(s).
Public/Granted literature
- US20090232844A1 IMMUNOPOTENTIATING COMPOUNDS Public/Granted day:2009-09-17
Information query
IPC分类: